World Media & Technology Corp (OTCMKTS:WRMT) is a micro-cap player in the wearable technology arm of the healthcare space that has captured the minds and hearts of the trading public in recent weeks in a striking fashion. That stock has been in full launch mode of late as the world wagers on the degree to which the company’s core tech will be able to disrupt the diabetes marketplace. The most recent catalyst driving shares is the company’s announcement that “its research activity generating non-invasive, continuous blood glucose estimates has been found to be sufficiently accurate to allow WRMT to proceed to full integration of the algorithm in the Helo platform so WRMT can offer blood glucose estimation as a service in Q4’17 to Helo wearers who choose to pay an initial set-up fee and an ongoing monthly charge.”
That appears to set up a push toward major top line growth later this year. According to the International Diabetes Federation, 415 million people worldwide (1 in 11 people) have diabetes consuming 12% of global health expenditure ($673B) in 2015. The American Diabetes Association advises that in the US, nearly 30 million (1 in 8) people have diabetes and $1 in $5 health care dollars is spent caring for people with diabetes. Americans with diagnosed diabetes incur average medical expenditures of about $13,700 per year, of which about $7,900 is attributed to diabetes.
World Media & Technology Corp (OTCMKTS:WRMT) trumpets itself as a company that designs, manufactures and sells connected, next-generation, innovative wearable devices and mobile products. It has end-users in over 80 countries which it supports through its exclusive distribution partnership with World Global Network.
According to company materials, “By deploying our proprietary Life Sensing Technology technology in our exquisitely and ergonomically designed, proprietary wearable devices, we provide immediate benefit to the wearer. In addition, by engaging in authorized data mining of the collective wearer data, we, together with our partners expect to discover breakthrough products and services.”
Find out when $WRMT stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
According to the company, Helo’s features today include measurement of Blood Pressure, ECG, Heart Rate, Respiration Rate, Heart Rate Variability (HRV) analysis for mood and energy levels along with measuring steps, distance and calorie burn.
However, this is the first time anyone has used a photoplethysmograph (PPG) to estimate blood glucose levels and incorporate the technology into a wearable device to provide convenient, non-invasive blood glucose estimation and logging on a continuous basis.
Fabio Galdi, CEO, World Media & Technology Corp., said, “I am personally excited by this development. It is the first time that I am aware that PPG technology has been used to estimate blood glucose in a wearable device designed for the consumer wellness market. It will address a very real, painful and expensive need. Our test results have proven consistent with traditional blood glucose measurements so we have decided to start integration to provide this as a full Helo service later this year.” He continued, “By the time that we launch, we will have enough Helo wearers all over the world to generate a very valuable blood glucose data base. Our plan is to share this data via our Big Data Portal with appropriate research partners. We are sure that together we can gain valuable insights and who knows, maybe somewhere, buried below all that data our research partners may find the cure for diabetes!”
Traders will note just under 590% added to share values of the stock over the past month of action. Market participants may want to pay attention to this stock. WRMT has a history of dramatic rallies. In addition, the stock has seen an influx in interest of late, with the stock’s recent average trading volume running just shy of 920% over the long run average.
This should not be overlooked with the stock trading on a float that is very limited at just 3.9M shares. It’s something the veterans know to key on: a mechanically driven price squeeze can result from this type of mix of small float and ramping attention from traders.
Now commanding a market cap of $685.7M, WRMT has a store ($404K) of cash on the books, which compares with virtually no total current liabilities. WRMT is pulling in trailing 12-month revenues of $1.7M. However, the company is seeing recent declines on the top line on a sequential quarterly basis, with revenues falling at -38.3% as of its latest reporting period. That said, the market is clearly looking ahead at the potential for recurring revenues as the story builds in 2017. You can bet we will update this one again as new information comes into view. For continuing coverage on shares of $WRMT stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!
